Pearson (PSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The UE5 implementation is reportedly 'in progress' and could help developers reduce shader stutter and long load times in ...
Pakistan is facing a sharp rise in fuel import costs as Middle East war disruptions drive diesel premiums to record highs.
Representative David Scott(D-GA) walks out after the vote on the 2nd part of the U.S. House of Representatives vote to hold ...
Alumis is preparing to file its oral TYK2 inhibitor envudeucitinib as a treatment for psoriasis later this year, after a pair of positive phase 3 trials. The South San Francisco biotech said ...
He said any positive developments were likely to drive market recovery, particularly given the improved diplomatic status of ...
WASHINGTON (TNND) — Senate DOGE Caucus Chair Joni Ernst, R-Iowa, led fellow Republicans on Wednesday in announcing an ...
Conversations are underway between Gov. Greg Abbott and Houston Mayor John Whitmire after the Houston City Council voted to ...
Almost 120 suburban train stations will no longer be manned by protective service officers in a bid to ramp up security at ...
Victoria Police has unveiled a major overhaul of PSO patrols at Melbourne’s train stations, revealing the areas where ...
Zasocitinib, which is a potent and highly selective TYK2 inhibitor would be a good option for some of our patients who are ...
Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results